Recent Financing
Recent Raise
Avalyn Pharma is a clinical-stage biopharma developing inhaled reformulations of approved antifibrotic drugs for targeted pulmonary delivery, advancing AP01, AP02, and a fixed-dose combination through clinical trials and manufacturing.
